RHO and melanoma: Both processes affect cytoskeleton modifications, for example, Atorvastatin has been shown to negatively regulate cell adhesion in patients with myocardial injury36 and other statins have anti-migratory and anti-adhesive effects in vitro in melanoma cells through suppression of Rho/ROCK signaling.37